Feb 01, 2017
|Name of listed company:||Chugai Pharmaceutical Co., Ltd.|
|Code number:||4519 (1st Section of Tokyo Stock Exchange)|
|Head office:||1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo|
|Chairman & CEO:||Osamu Nagayama|
|Inquiries to:||Masahiko Uchida,
General Manager, Corporate Communications Dept.
F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its financial results for fiscal 2016 (January 1 – December 31, 2016).
Roche owns 59.89% of Chugai's outstanding shares (61.36% of the total number of shares issued excluding treasury stock) as of end of December 2016.
Its press release and presentation materials can be found on its website (http://www.roche.com).
Chugai’s performance for the period of January 1 to December 31, 2016 is included in the announced Roche Group’s results.
|Media Releases||Investor Updates||Presentation||Annual Report|
[ PDF 96KB]
To view PDF files,
you will need Adobe® Reader® which is available as a free download.